AlzBiomarker
Control vs Alzheimer's Disease: GFAP (CSF)
Meta-analysis of five studies revealed a non-significant trend towards lower levels of glial fibrillary acid protein (GFAP) in the cerebrospinal fluid of control subjects compared with people with Alzheimer's disease (effect size = 0.666, p = 0.055).
Loading data...